Cary Street Partners Investment Advisory LLC Tekla Life Sciences Investors Transaction History

Cary Street Partners Investment Advisory LLC

$2.63 Billion
Q3 2024

1 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2022 Feb 14, 2023	BUY	$13.55 - $15.23 $52,750 - $59,290	3,893 New	3,893 $55,000

Others Institutions Holding HQL

# of Institutions

Shares Held

9.29M

Call Options Held

Put Options Held

Saba Capital Management, L.P. New York, NY

3.43M
Shares

$47.3 Million
1.1% of portfolio
Penserra Capital Management LLC Orinda, CA

776K
Shares

$10.7 Million
0.25% of portfolio
Morgan Stanley New York, NY

490K
Shares

$6.75 Million
0.0% of portfolio
Karpus Management, Inc. Pittsford, NY

469K
Shares

$6.46 Million
0.23% of portfolio
Sit Investment Associates Inc Minneapolis, MN

417K
Shares

$5.75 Million
0.14% of portfolio

View Full List

About TEKLA LIFE SCIENCES INVESTORS

Ticker HQL
Exchange NYSE
Sector Financial Services
Industry Asset Management
Description
Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical...

More about HQL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cary Street Partners Investment Advisory LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cary Street Partners Investment Advisory LLC with notifications on news.

Account